AGIO Stock Summary and Trading Ideas (Agios Pharmaceuticals | NASDAQ:AGIO)

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Pharmaceuticals trades on the NASDAQ stock market under the symbol AGIO.

As of November 3, 2026, AGIO stock price climbed to $31.20 with 611,288 million shares trading.

AGIO has a beta of 2.15, meaning it tends to be more sensitive to market movements. AGIO has a correlation of 0.09 to the broad based SPY ETF.

AGIO has a market cap of $1.86 billion. This is considered a Small Cap stock.

Last quarter Agios Pharmaceuticals reported $45 million in Revenue and -$1.69 earnings per share. This beat revenue expectation by $19 million and exceeded earnings estimates by $.02.

In the last 3 years, AGIO traded as high as $62.58 and as low as $20.40.

The top ETF exchange traded funds that AGIO belongs to (by Net Assets): VTI, XBI, IWM, VB, VBK.

AGIO has underperformed the market in the last year with a price return of -27.8% while the SPY ETF gained +11.7%. However, in the short term, AGIO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.9% vs +1.2% return in SPY. But in the last 2 weeks, AGIO shares have been beat by the market, returning -10.6% compared to an SPY return of -1.6%.

AGIO support price is $28.85 and resistance is $31.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGIO shares will trade within this expected range on the day.